Delivery Order SPE2DB24D2105-SPE2DB24FAPDG

Award Date 4/26/24
Potential Completion Date 4/29/24
Potential Value $42K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,337.92 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty medication. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,738.06 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of December 19, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $31,505.16 delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award, valued at $42,100.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a...
This federal contract award, valued at $80,684.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,684.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of STELARA 45 MG/0.5 ML Syringes, a specialty medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 23, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $32,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm-fixed price delivery order contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024, and does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,014.95 firm fixed-price delivery order is for STELARA 90 MG/ML syringes, with a completion date of May 9, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $78,749.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which runs through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,490.58 Firm Fixed Price Delivery Order contract is for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB24FAPDG
    Delivery Order

This federal contract award, valued at $42,499.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML syringes and has an ultimate completion date of April 29, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/16/25, 12:02 PM